NDC 70069-836-01
Bortezomib 3.5 mg/3.5mL
bortezomib · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Bortezomib is a proteasome inhibitor injection used to treat certain types of cancer, including multiple myeloma and mantle cell lymphoma. It works by blocking proteins in cancer cells that help them grow and survive.
Key Facts
- Brand Name
- Bortezomib
- Generic Name
- bortezomib
- NDC Code (Package)
70069-836-01- NDC Code (Product)
70069-836- Manufacturer
- Somerset Therapeutics LLC
- Strength
- 3.5 mg/3.5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA211898
- Drug Class
- Proteasome Inhibitor [EPC]
- Marketing Start
- 04/29/2025
Recall History
No Recall HistoryView Full Drug Page
Bortezomib — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.